MHRA approves aumolertinib to treat non-small cell lung cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 3 June 2025, approved aumolertinib (Aumseqa) for adult patients with...
Cell
Bayer’s sevabertinib gets priority review for treatment of non-small cell lung cancer
Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) and granted...
New Study Uncovers Mechanism Behind Lung Stem Cell Differentiation in IPF
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterized by scarring, resulting from the improper differentiation of lung stem...
US FDA approves Amgen drug for small cell lung cancer, Health News, ET HealthWorld
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
The other, smaller (cell) lung cancer
Approximately 125,000 people in the U.S. will die from lung cancer this year and more than twice as many will...
Non-Small Cell Lung Cancer Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Renub Research has released a report titled “Non-Small Cell Lung Cancer Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast...
